Literature DB >> 21426725

[Adamantane resistance among seasonal influenza A viruses between January to October in Guangzhou, 2009].

Zi-Feng Yang1, Wen-da Guan, Guo-Rong Xu, Ming-Yuan Li, Zi-Yao Mo, Yi Luo, Wan-Ni Dong, Yu-Tao Wang, Sheng Qin, Yang-Qing Zhan, Xue Zhang, Qun-di Huang, Shui-Shan Zhao, Rong Zhou, Rong-Chang Chen, Nan-Shan Zhong.   

Abstract

OBJECTIVE: To study the prevalence of adamantane-resistance among influenza A viruses isolated from Guangzhou between January and October in 2009, and to provide more information for clinical usage of adamantane drugs.
METHODS: Totally 311 influenza A strains isolated from 6 hospitals in Guangzhou between January and October in 2009 were selected, and the MP gene of all 311 strains (159 strains of H1 subtype, 152 strains of H3 subtype) was sequenced. The susceptibility of viruses to rimantadine was assayed by biological methods in cells. RESULT: A hundred and forty-eight strains of influenza A (H1) viruses (93.1%, 148/159) were resistant to the adamantanes, and all the 152 influenza A (H3) viruses were resistant to the adamantanes. An amino acid substitution S31N was found in most of the strains except 1 strain with double mutation V27A/S31N. Furthermore, the M gene of influenza A (H1) viruses was divided into genotype B (human) (97/159) and genotype F (European and Australian birds, 62/159), while the M gene of influenza A (H3) viruses was genotype B (human) (152/152).
CONCLUSION: Resistance rate of seasonal influenza A viruses isolated from Guangzhou was high. The MP gene of influenza A (H1) may be replaced by a gene from European and Australian birds through a reassortment event.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21426725

Source DB:  PubMed          Journal:  Zhonghua Jie He He Hu Xi Za Zhi        ISSN: 1001-0939


  4 in total

Review 1.  Re-understanding anti-influenza strategy: attach equal importance to antiviral and anti-inflammatory therapies.

Authors:  Zhengtu Li; Li Li; Shuai Zhao; Jing Li; Hongxia Zhou; Yunhui Zhang; Zifeng Yang; Bing Yuan
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

2.  Efficacy and safety of Ban-Lan-Gen granules in the treatment of seasonal influenza: study protocol for a randomized controlled trial.

Authors:  Zheng-tu Li; Li Li; Ting-ting Chen; Chu-yuan Li; De-qin Wang; Zi-feng Yang; Nan-shan Zhong
Journal:  Trials       Date:  2015-03-28       Impact factor: 2.279

3.  Efficacy of delayed treatment of China-made Peramivir with repeated intravenous injections in a mouse influenza model: from clinical experience to basal experiment.

Authors:  Zhengtu Li; Runfeng Li; Jing Li; Hui Xie; Yanbing Hao; Qiuling Du; Tingting Chen; Yimin Li; Rongchang Chen; Zifeng Yang; Nanshan Zhong
Journal:  BMC Infect Dis       Date:  2016-07-08       Impact factor: 3.090

4.  Efficacy and safety of Re-Du-Ning injection in the treatment of seasonal influenza: results from a randomized, double-blinded, multicenter, oseltamivir-controlled trial.

Authors:  Yu Liu; Wei Mu; Wei Xiao; Bao-Lin Wei; Lan Wang; Xin-Qiao Liu; Xu-Dong Xiong; Xiao-Min Huang; Ye-Qing Zhang; Hai-Ming Chen; Feng-Jie Yan; Yu-Ping Tan; Yu-Hong Huang
Journal:  Oncotarget       Date:  2017-07-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.